Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
01 February, 2015 01:23 IST
Astrazeneca Pharma turns to loss in Q3
Source: IRIS | 06 Feb, 2013, 05.31PM
Comments  |  Post Comment

Astrazeneca Pharma India, an integrated biopharmaceutical company, posted net loss of Rs 176.95 million for the quarter ended Dec. 31, 2012 as compared to net profit of Rs 149.37 million for the same period in the previous year.

Net sales has decreased 31.65% to Rs 1.05 billion for the quarter ended Dec 31, 2012 from Rs 1.54 billion for the same period in the previous year.

Shares of AstraZeneca declined Rs 2.65, or 0.2%, to settle at Rs 1,323.65. The total volume of shares traded was 2,529 at the BSE (Wednesday).

Astrazeneca Pharma India Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
Whirlpool of India standalone quarterly earnings surge 48.42% - 30-Jan-2015 19:19
Shriram Transport Finance board elevates Lakshminarayanan as chairman - 30-Jan-2015 17:26
Tech Mahindra consolidated quarterly profit declines 20.25% - 30-Jan-2015 15:49
Binani Industries swings to profit in Oct-Dec quarter - 30-Jan-2015 15:43
NTPC standalone quarterly net climbs 7.43% - 30-Jan-2015 15:38
Kirloskar Brothers swings to loss in Oct-Dec quarter - 30-Jan-2015 15:35
Adani Enterprises consolidated quarterly profit soars 6.51 times - 30-Jan-2015 15:30
JSW Steel consolidated quarterly profit drops 29.49% - 30-Jan-2015 15:25
Monsanto India standalone quarterly net drops 25.76% - 30-Jan-2015 15:20
Dabur India consolidated Q3 profit climbs 16.5% - 30-Jan-2015 14:55
Siemens Q1 profit surges to Rs 6.34 bn - 30-Jan-2015 14:47
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer